A Comparison of Adverse Effect Profiles of Two Anti-Il-5 Therapies in Adults With Uncontrolled Asthma

The Showa University Journal of Medical Sciences
doi 10.15369/sujms.29.279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Showa University Society

Related search

Efficacy, Adverse Events, and Inter-Drug Comparison of Mepolizumab and Reslizumab Anti-Il-5 Treatments of Severe Asthma – A Systematic Review and Meta-Analysis

European Clinical Respiratory Journal
2018English

Comparison of Anti-Interleukin-5 Therapies in Patients With Severe Asthma: Global and Indirect Meta-Analyses of Randomized Placebo-Controlled Trials

Clinical and Experimental Allergy
AllergyImmunology
2016English

A Review of Three New Anti-Interleukin-5 Monoclonal Antibody Therapies for Severe Asthma

Cureus
2018English

A Meta-Analysis of Anti-Interleukin-13 Monoclonal Antibodies for Uncontrolled Asthma

PLoS ONE
Multidisciplinary
2019English

Inhaler Technique Among Adults With Uncontrolled Asthma From Low-Income Philadelphia Neighborhoods

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Effect of Asthma Therapies on the Natural Course of Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2016English

Anti-Type2-Antibodies Specifically Inhibit Murine Asthma Features Induced by Intranasal Application of IL-5 and IL-13

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Home Visits for Uncontrolled Asthma Among Low-Income Adults With Patient Portal Access

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

RANKL Inhibition by Osteoprotegerin Prevents Bone Loss Without Affecting Local or Systemic Inflammation Parameters in Two Rat Arthritis Models: Comparison With Anti-TNFα or Anti-Il-1 Therapies

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy